Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Autor: Qi, Litong, Liu, Dexue, Qu, Yanling, Chen, Beijian, Meng, Haiyan, Zhu, Lei, Li, Lipeng, Wang, Shuqing, Liu, Changyi, Zheng, Guanzhong, Lian, Qiufang, Yin, Guotian, Lv, Lingchun, Lu, Di, Chen, Xiaoshu, Xue, Fengtai, An, Pei, Li, Haoyu, Deng, Huan, Li, Li, Qian, Lei, Huo, Yong
Zdroj: In JACC: Asia August 2023 3(4):636-645
Databáze: ScienceDirect